NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
US carries out first airdrop of aid into Gaza
America's best fast food restaurants ranked
FIFA seals closer ties to Saudi Arabia with World Cup sponsor deal for oil firm Aramco
Conan O'Brien reveals the WORST 'amateur move' a talk
Police release name, photo of 'dangerous' suspect in kidnapping
Geena Davis, 68, wows in a figure
Mia Regan sweetly embraces Victoria Beckham as they reunite at her Mango launch event in Spain
Kanye West's ex Julia Fox gives Bianca Censori a run for her money in an X
Woman, 43, accused of murdering her disabled mother
Person in serious condition after incident in Feilding